These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 33645040
1. [Effect of Dahuang Zhechong Pills combined with TACE on VEGF, MMP-2, TGF-β1 and immune function of patients with primary liver cancer (blood stasis and collaterals blocking type)]. Dai CM, Jin S, Zhang JZ. Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):722-729. PubMed ID: 33645040 [Abstract] [Full Text] [Related]
2. Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study. Lai X, Wang A. Comput Intell Neurosci; 2022 Feb; 2022():6336107. PubMed ID: 36052044 [Abstract] [Full Text] [Related]
3. Evaluation of the efficacy of aparatinib and carrilizumab combined with transcatheter arterial chemoembolization in the treatment of primary hepatocellular carcinoma. Chen C, Duan XT, Li GY, Hao XJ, Wang WL, Shen YF, Zhang SH. Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4135-4144. PubMed ID: 37203839 [Abstract] [Full Text] [Related]
4. Efficacy of Lenvatinib in Combination With PD-1 Monoclonal Antibody and Interventional Treatment for Intermediate-Stage Hepatocellular Carcinoma: Impact on Serum Vascular Endothelial Growth Factor and Matrix Metalloproteinase-9 Levels: A Retrospective Study. Zhu J, Wu Y, Zhang H, Yang J, An Y, Shao S, Xia N. Technol Cancer Res Treat; 2024 May; 23():15330338241256812. PubMed ID: 38802996 [Abstract] [Full Text] [Related]
7. Observation of efficacy of TACE combined with HIFU on patients with middle-advanced liver cancer. Zhang Q, Bian SQ, Lv W, Kou D, Hu HL, Guo SS, Cao ZS. Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):239-246. PubMed ID: 31389607 [Abstract] [Full Text] [Related]
8. Sorafenib combined with transarterial chemoembolization prolongs survival of patients with advanced hepatocellular carcinoma. Liu Q, Dai Y. J BUON; 2020 Aug; 25(2):945-951. PubMed ID: 32521890 [Abstract] [Full Text] [Related]
9. Comparison of Efficiency of TACE plus HIFU and TACE alone on Patients with Primary Liver Cancer. Luo Y, Jiang Y. J Coll Physicians Surg Pak; 2019 May; 29(5):414-417. PubMed ID: 31036108 [Abstract] [Full Text] [Related]
10. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer. Lu B, Zhu L, Wang X, Zhong L, Cheng Y, Fan J, Yu L. J BUON; 2019 May; 24(5):1979-1984. PubMed ID: 31786864 [Abstract] [Full Text] [Related]
11. Correlations of serum VEGF and MMP-2 levels with CLM in CRC patients and effects of TACE on their expressions. Xu H, Ren YJ, Liu K, Min XL, Yang L, Zhou Y, Zheng J, Yang C. Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3394-3401. PubMed ID: 29917190 [Abstract] [Full Text] [Related]
12. Effects of image-guided adaptive radiotherapy combined with hepatic artery chemoembolization in primary liver cancer patients. Zhao Y, Zhang C, Zhang Y, Bo C, An Y, Li N, Ma W, Zou C, Zhao L, Zhang S. Clin Res Hepatol Gastroenterol; 2022 May; 46(5):101889. PubMed ID: 35183790 [Abstract] [Full Text] [Related]
13. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. Qian J, Oppermann E, Tran A, Imlau U, Qian K, Vogl TJ. World J Gastroenterol; 2016 Jun 07; 22(21):5042-9. PubMed ID: 27275096 [Abstract] [Full Text] [Related]
14. Transcatheter Arterial Chemoembolisation Combined with Radiofrequency Ablation on Hepatocellular Carcinoma and Levels of Relevant Markers. Feng J, Yang JH, Li JH, Jin XS, Sun Q. J Coll Physicians Surg Pak; 2020 Mar 07; 30(3):259-262. PubMed ID: 32169132 [Abstract] [Full Text] [Related]
15. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients. Guan HT, Wang J, Yang M, Song L, Tong XQ, Zou YH. Chin Med J (Engl); 2013 Mar 07; 126(19):3651-5. PubMed ID: 24112158 [Abstract] [Full Text] [Related]
16. Dahuang Zhechong pills inhibit liver cancer growth in a mouse model by reversing Treg/Th1 balance. Chen TT, DU SL, Wang SJ, Wu L, Yin L. Chin J Nat Med; 2022 Feb 07; 20(2):102-110. PubMed ID: 35279237 [Abstract] [Full Text] [Related]
17. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma. Yuan P, Zhang Z, Kuai J. J BUON; 2019 Feb 07; 24(1):163-170. PubMed ID: 30941966 [Abstract] [Full Text] [Related]
18. Efficacy of endostar combined with transcatheter arterial chemoembolization and analysis of vascular endothelial factor and C-reactive protein levels in patients with advanced hepatocellular carcinoma under contrast enhanced ultrasound. Wang Y, Xuan Z, Zheng X, Han R, Zhou L, Liu H, Liu Y. J BUON; 2020 Feb 07; 25(1):407-414. PubMed ID: 32277662 [Abstract] [Full Text] [Related]
19. Poor prognosis for hepatocellular carcinoma with transarterial chemoembolization pre-transplantation: retrospective analysis. Li HL, Ji WB, Zhao R, Duan WD, Chen YW, Wang XQ, Yu Q, Luo Y, Dong JH. World J Gastroenterol; 2015 Mar 28; 21(12):3599-606. PubMed ID: 25834326 [Abstract] [Full Text] [Related]
20. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis]. Luo J, Zheng JP, Shao GL, Wen S, Guo LW, Zeng H, Zhang L, Qian CY, Hao WY. Zhonghua Gan Zang Bing Za Zhi; 2018 Apr 20; 26(4):298-304. PubMed ID: 29996343 [Abstract] [Full Text] [Related] Page: [Next] [New Search]